BetaGI-IgG intron for enhanced antiIGF1 R expression

Details for Australian Patent Application No. 2009314111 (hide)

Owner Schering Corporation Saha, D.

Inventors Saha, Deba P.

Agent Spruson & Ferguson

Pub. Number AU-A-2009314111

PCT Pub. Number WO2010/056816

Priority 61/113,807 12.11.08 US

Filing date 12 November 2009

Wipo publication date 20 May 2010

International Classifications

C07K 16/22 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 15/67 (2006.01) Mutation or genetic engineering - General methods for enhancing the expression

Event Publications

9 June 2011 PCT application entered the National Phase

  PCT publication WO2010/056816 Priority application(s): WO2010/056816

15 September 2011 Alteration of Name

  The name of the applicant has been altered to Schering Corporation

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009314114-Ultra-low sulfur fuel and method for reduced contrail formation

2009314110-Simultaneous measurment of the in vivo metabolism of isoforms of a biomolecule